News

Article

AJMC® in the Press, May 10, 2024

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from Memory Care Business referenced a review published in a September 2022 supplement to The American Journal of Managed Care® (AJMC®) focusing on advancing Alzheimer disease treatment. The supplement article, “The Economic and Societal Burden of Alzheimer Disease: Managed Care Considerations,” highlighted that Alzheimer disease treatment could cost an estimated $321 billion in 2022, with costs expected to increase to $1 trillion in 2050.

An article from Business A.M. referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Contributor: In the Misdiagnosis of Menopause, What Needs to Change?” highlighted that 80% of medical residents felt barely comfortable discussing menopause and only 20% of residency programs for obstetrics and gynecology offered menopause training.

Related Videos
Kimberly Westrich, MA, chief strategy officer, NPC
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Raj Chovatiya, MD, PhD, MSCI.
1 expert in this video
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo